Inicio \ Investigación \ Publicaciones científicas \


Pancreatic adenocarcinoma treated with surgical resection, toceranib phosphate and firocoxib in a dog: a case report

Artículo de investigación publicado en Veterinary Research Communications

1 de junio de 2024

Exocrine pancreatic carcinomas are rarely reported in dogs. A ductal pancreatic adenocarcinoma in a 10-year-old intact beagle is described in this report. The diagnosis was made based on clinical signs, imaging (abdominal ultrasound and CT scan) and histopathology. Treatment consisted of partial right lobe pancreatectomy followed by adjuvant therapy with toceranib phosphate (Palladia®) and firocoxib (Previcox®) for six months. The treatment was well tolerated, and the survival time was 445 days. To our knowledge, this is the longest survival reported in the literature for a dog diagnosed with exocrine pancreatic adenocarcinoma. The results described here may contribute to provide a better understanding about this neoplasia and potential treatment options




Fuertes-Recuero M., Vazquez-Fernandez E., Lizasoain-Sanz G., Arroba-Alonso A., Sanchez-Lopez A., Martinez-de Merlo E., Suarez-Redondo M. y Ortiz-Diez G.




Ver artículo
Pancreatic adenocarcinoma treated with surgical resection, toceranib phosphate and firocoxib in a dog: a case report

Ver en NLM PubMed
Pancreatic adenocarcinoma treated with surgical resection, toceranib phosphate and firocoxib in a dog: a case report



Participantes:

Universidad ComplutenseDepartamento de Fisiología (Fisiología Animal). Departamento de Medicina y Cirugía Animal. Facultad de Veterinaria. Universidad Complutense (UCM).

Universidad ComplutenseHospital Clínico Veterinario Complutense (HCVC). Universidad Complutense (UCM).

Universidad ComplutenseServicio de Patología y Veterinaria Forense (SAP). Centro de Vigilancia Sanitaria Veterinaria (VISAVET). Universidad Complutense (UCM).







Veterinary Research Communications
FACTOR YEAR Q
1.800 2023

NLMID: 8100520

PMID: 38453822

ISSN: 0165-7380



TÍTULO: Pancreatic adenocarcinoma treated with surgical resection, toceranib phosphate and firocoxib in a dog: a case report


REVISTA: Vet Res Commun


NUMERACIÓN: 48(3):1921-1927


AÑO: 2024


EDITORIAL: Springer


AUTORES: Fuertes-Recuero M., Vazquez-Fernandez E., Lizasoain-Sanz G., Arroba-Alonso A., Sanchez-Lopez A., Martinez-de Merlo E., Suarez-Redondo M. and Ortiz-Diez G.


DOI: https://doi.org/10.1007/s11259-024-10349-5


CITA ESTA PUBLICACIÓN:

Fuertes-Recuero M., Vazquez-Fernandez E., Lizasoain-Sanz G., Arroba-Alonso A., Sanchez-Lopez A., Martinez-de Merlo E., Suarez-Redondo M. y Ortiz-Diez G. Pancreatic adenocarcinoma treated with surgical resection, toceranib phosphate and firocoxib in a dog: a case report. Veterinary Research Communications. 48(3):1921-1927. 2024. (A). ISSN: 0165-7380. DOI: 10.1007/s11259-024-10349-5


SERVICIOS: